ASCO '23 Entrees
OncoPharm
00:00
Axesell and Yascarda in Large B-Cell Lymphoma
Axesell or Yascarda in large B-cell lymphoma, patients who relapsed or had refractor disease that were left within 12 months of their first refinishing chemotherapy. We see an overall survival benefit here with Axesell compared to chemo and autologous stem cell transplant which had been the standard of CAR. Those cat microbes are also striking in that they look like a waterfall that then turns into a very flat stream both for our PFS and event free survival.
Transcript
Play full episode
